Literature DB >> 2579127

T cell responses to Mls determinants are restricted by cross-reactive MHC determinants.

D H Lynch, R E Gress, B W Needleman, S A Rosenberg, R J Hodes.   

Abstract

The studies presented here investigated the relationship between T cell recognition of MHC-encoded products and non-MHC-linked Mls determinants. The first aspect addressed whether Mls-reactive T cells recognize Mls-encoded products alone or in association with MHC-encoded determinants. Initial studies used Mlsa-specific T cell clones that were generated by repeated stimulation of C57BL/6 or B10.A(5R) spleen cells with DBA/2 lymphoid cells. These clones recognized Mlsa on cells expressing MHC products of the H-2b, H-2d, and H-2k haplotypes, but not the H-2q haplotype. Thus, these cloned T cells were found to recognize Mlsa products in association with public but demonstrably polymorphic H-2 determinants. The question of whether T cell clones that were specific for self-H-2 determinants (autoreactive) or soluble antigen plus syngeneic H-2 (antigen-specific) could also be stimulated by Mlsa determinants was also addressed. A substantial proportion of the antigen-specific or autoreactive T cell clones tested were stimulated by Mlsa determinants. Furthermore, stimulation of these clones by Mlsa was H-2 restricted. The pattern of H-2-restricted recognition of Mlsa by these clones was not distinguishable from that observed in the Mlsa-specific T cell clones, nor was it influenced by the primary specificity or H-2 restriction pattern of a given clone. Although these findings provide a means of explaining the observation that Mls-reactive T cells exist at extremely high precursor frequencies, they also raise questions regarding the nature of the receptor structures which are used by a single T cell in the recognition of two or more apparently distinct stimuli.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2579127

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  12 in total

1.  Allostimulatory analysis of a newly-defined and widely-distributed Mls superantigen.

Authors:  J J Ryan; H B LeJeune; J J Mond; F D Finkelman
Journal:  Immunogenetics       Date:  1991       Impact factor: 2.846

2.  Allogeneic substitution for nominal antigen-specific T-cell clone reactivity in schistosomiasis.

Authors:  G P Linette; P J Lammie; S M Phillips
Journal:  Immunology       Date:  1986-04       Impact factor: 7.397

Review 3.  Virus-encoded superantigens.

Authors:  B T Huber; P N Hsu; N Sutkowski
Journal:  Microbiol Rev       Date:  1996-09

4.  The expression of Mlsc determinants on Mlsa, Mlsb, and Mlsx prototypic strains.

Authors:  R Abe; R J Hodes
Journal:  Immunogenetics       Date:  1988       Impact factor: 2.846

Review 5.  Recognition of multiple class II signals by murine T cell antigen receptors. Speculation regarding the relationships among autoreactive, antigen-specific and alloreactive T cells.

Authors:  B W Needleman
Journal:  Immunol Res       Date:  1988       Impact factor: 2.829

6.  A third T-cell receptor beta-chain variable region gene encodes reactivity to Mls-1a gene products.

Authors:  M P Happ; D L Woodland; E Palmer
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

7.  H-2-linked genes determine the level of the primary in vitro anti-Mls response.

Authors:  S Macphail; O Stutman
Journal:  Immunogenetics       Date:  1986       Impact factor: 2.846

8.  Selective anergy of V beta 8+,CD4+ T cells in Staphylococcus enterotoxin B-primed mice.

Authors:  Y Kawabe; A Ochi
Journal:  J Exp Med       Date:  1990-10-01       Impact factor: 14.307

9.  Clonal analysis of the Mls system. A reappraisal of polymorphism and allelism among Mlsa, Mlsc, and Mlsd.

Authors:  R Abe; J J Ryan; R J Hodes
Journal:  J Exp Med       Date:  1987-04-01       Impact factor: 14.307

10.  An exogenous mouse mammary tumor virus with properties of Mls-1a (Mtv-7).

Authors:  W Held; A N Shakhov; G Waanders; L Scarpellino; R Luethy; J P Kraehenbuhl; H R MacDonald; H Acha-Orbea
Journal:  J Exp Med       Date:  1992-06-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.